Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01948609 · ClinicalTrials.gov registry record
Prospective Research of Outcomes After Salpingo-oophorectomy
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 100
- Enrollment target
NCT01948609 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 100 participants.
The verdict
NCT01948609 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
PROSper is a prospective cohort study of 100 women 35-50 years of age with BRCA 1/2 mutations who have elected to either undergo risk reducing salpingo-oophorectomy (RRSO) or nonsurgical management. The investigators will compare the change in cardiovascular health, bone health, sexual function, quality of life, and menopausal symptoms over 3 years of follow-up between women who undergo RRSO (baseline just prior to surgery) and age-matched controls that do not undergo RRSO. The investigators hypothesis is that women who undergo a premature surgical menopause induced by RRSO have worse cardiovascular health and bone health compared with women who do not undergo RRSO.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-07 |
| Est. Completion | 2021-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01948609
The ClinicalTrials.gov registry entry for NCT01948609 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01948609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01948609 about?
NCT01948609 is a clinical study titled "Prospective Research of Outcomes After Salpingo-oophorectomy". PROSper is a prospective cohort study of 100 women 35-50 years of age with BRCA 1/2 mutations who have elected to either undergo risk reducing salpingo-oophorectomy (RRSO) or nonsurgical management. The investigators will compare the change in cardiovascular health, bone health, sexual function, qua...
What is the current status of trial NCT01948609?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2014-07. Estimated completion is 2021-12.
Who is sponsoring clinical trial NCT01948609?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.